SEMA3C and hepatocellular carcinoma: Furthermore, analysis of the TCGA-LIHC database revealed that HCC patients with high Sema3C expression and the presence of FAP+ CAFs subset showed a significant association with advanced tumor stages/T stages compared to those with low Sema3C expression and FAP+ CAFs.